IQ-AI (IQAI) Competitors GBX 1.02 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines IQAI vs. INHC, FDBK, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and RENXShould you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Induction Healthcare Group (INHC), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry. IQ-AI vs. Induction Healthcare Group Feedback DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Kooth Renalytix IQ-AI (LON:IQAI) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Does the MarketBeat Community prefer IQAI or INHC? Induction Healthcare Group received 8 more outperform votes than IQ-AI when rated by MarketBeat users. Likewise, 93.33% of users gave Induction Healthcare Group an outperform vote while only 66.67% of users gave IQ-AI an outperform vote. CompanyUnderperformOutperformIQ-AIOutperform Votes666.67% Underperform Votes333.33% Induction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67% Does the media refer more to IQAI or INHC? In the previous week, Induction Healthcare Group's average media sentiment score of 0.44 beat IQ-AI's score of 0.00 indicating that Induction Healthcare Group is being referred to more favorably in the news media. Company Overall Sentiment IQ-AI Neutral Induction Healthcare Group Neutral Which has higher valuation & earnings, IQAI or INHC? IQ-AI has higher earnings, but lower revenue than Induction Healthcare Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQ-AI£538.19K4.22N/AN/AN/AInduction Healthcare Group£13.65M0.57-£3.25M-£0.03-275.00 Do analysts prefer IQAI or INHC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQ-AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AInduction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do insiders and institutionals hold more shares of IQAI or INHC? 46.3% of Induction Healthcare Group shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, IQAI or INHC? IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the S&P 500. Is IQAI or INHC more profitable? Induction Healthcare Group has a net margin of -23.86% compared to IQ-AI's net margin of -77.52%. Induction Healthcare Group's return on equity of -14.53% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets IQ-AI-77.52% -140.75% -22.03% Induction Healthcare Group -23.86%-14.53%-7.32% SummaryInduction Healthcare Group beats IQ-AI on 8 of the 12 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get IQ-AI News Delivered to You Automatically Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQAI vs. The Competition Export to ExcelMetricIQ-AIHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£2.27M£218.32M£5.40B£1.59BDividend Yield17.30%6.58%5.13%11.05%P/E Ratio-13.67652.83113.461,740.37Price / Sales4.22338.721,484.40230,520.65Price / Cash10.2543.5739.6435.87Price / BookN/A4.924.652.88Net IncomeN/A-£5.00M£119.06M£144.83M7 Day PerformanceN/A0.53%0.79%0.11%1 Month Performance-7.66%-1.12%5.65%-0.11%1 Year Performance-73.72%10.97%36.76%15.28% IQ-AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQAIIQ-AIN/AGBX 1.03flatN/A-75.6%£2.27M£538,190.00-13.676Gap UpINHCInduction Healthcare GroupN/AGBX 8.34-1.9%N/A-67.3%£7.82M£13.65M-277.8374Gap DownFDBKFeedbackN/AGBX 44.85+3.1%N/A-42.1%£5.98M£1.02M-172.5024Gap UpHigh Trading VolumeDVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.65-3.7%N/A-87.1%£1.05M£35,000.00-21.6731Gap DownSENSSensyne HealthN/AGBX 0.35-33.3%N/A+0.0%£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/A+0.0%£1.23B£176.86M4,085.111,560CRWCraneware2.3159 of 5 starsGBX 1,995+0.8%GBX 2,700+35.3%+23.7%£705.03M£189.27M7,673.08734High Trading VolumeINSInstemN/AGBX 830flatN/A+8.5%£199.62M£61.63M5,928.57500KOOKooth3.0039 of 5 starsGBX 174-1.1%GBX 585+236.2%-43.0%£63.48M£54.17M1,450.00478Insider BuyingHigh Trading VolumeRENXRenalytixN/AGBX 7.55-5.6%N/A-81.8%£12.53M£2.29M-31.46102Gap Up Related Companies and Tools Related Companies Induction Healthcare Group Alternatives Feedback Alternatives DeepVerge Alternatives Trellus Health Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Kooth Alternatives Renalytix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IQAI) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ-AI Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IQ-AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.